Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1

Conditions

Sarcoma 434Osteosarcoma 131Sarcoma, Ewing 89Melanoma 81Rhabdomyosarcoma 78Neoplasms 70Gastrointestinal Stromal Tumors 63Neuroblastoma 62Bone Neoplasms 62Colorectal Neoplasms 60Breast Neoplasms 60Ovarian Neoplasms 58Glioblastoma 55Neoplasm Metastasis 52Liposarcoma 49Dendritic Cell Sarcoma, Interdigitating 44Carcinoma, Non-Small-Cell Lung 44Gliosarcoma 42Stomach Neoplasms 40Pancreatic Neoplasms 40Leiomyosarcoma 40Lymphoma 37Glioma 35Carcinoma, Renal Cell 35Sarcoma, Synovial 34Rhabdoid Tumor 34Neurofibrosarcoma 34Uterine Cervical Neoplasms 33Sarcoma, Kaposi 33Lymphoma, Non-Hodgkin 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Arteriovenous Malformations × Sarcoma × 1 year × Clear all
NCT02625389 2025-10-10

A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures

Guerbet

Phase 4 Completed
132 enrolled 9 charts
Sarcoma

Arteriovenous Malformations, Hemangioendothelioma, Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡